More and more, as momentum builds for the soon-to-be-blockbuster Winrevair, Merck’s $11.5 billion buyout of Acceleron in 2021 is looking like a savvy move. | Paving the way for the label update were ...
The figures, published today [Tuesday, 12 January] are from latest publication of the NICE Technology Appraisals in the NHS in England - Innovation Scorecard. Published by the Health and Social Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback